Another experimental study reported that in Aβ42-induced rats, β-asarone improved cognitive impairment and alleviated Aβ deposition by protecting astrocytes, which was possibly achieved by reducing the levels of TNF-α and IL-1β and then downregulating AQP4 expression [87]. The gene discussed is AQP4; the disease is Cognitive impairment.